mtDNA Maintenance and Alterations in the Pathogenesis of Neurodegenerative Diseases

Modesti, L.; Danese, A.; Angela Maria Vitto, V.; Ramaccini, D.; Aguiari, G.; Gafà, R.; Lanza, G.; Giorgi, C.; Pinton, P. Mitochondrial Ca2+ signaling in health, disease and therapy. Cells, 2021, 10(6), 1317.
[http://dx.doi.org/10.3390/cells10061317] [PMID: 34070562]

Singh, L.N.; Kao, S.H.; Wallace, D.C. Unlocking the complexity of mitochondrial DNA: A key to understanding neurodegenerative disease caused by injury. Cells, 2021, 10(12), 3460.
[http://dx.doi.org/10.3390/cells10123460] [PMID: 34943968]

Rone, M.B.; Fan, J.; Papadopoulos, V. Cholesterol transport in steroid biosynthesis: Role of protein–protein interactions and implications in disease states. Biochim. Biophys. Acta Mol. Cell Biol. Lipids, 2009, 1791(7), 646-658.
[http://dx.doi.org/10.1016/j.bbalip.2009.03.001] [PMID: 19286473]

Wang, B.; Huang, M.; Shang, D.; Yan, X.; Zhao, B.; Zhang, X. Mitochondrial behavior in axon degeneration and regeneration. Front. Aging Neurosci., 2021, 13, 650038.
[http://dx.doi.org/10.3389/fnagi.2021.650038] [PMID: 33762926]

Figueira, T.R.; Barros, M.H.; Camargo, A.A.; Castilho, R.F.; Ferreira, J.C.B.; Kowaltowski, A.J.; Sluse, F.E.; Souza-Pinto, N.C.; Vercesi, A.E. Mitochondria as a source of reactive oxygen and nitrogen species: From molecular mechanisms to human health. Antioxid. Redox Signal., 2013, 18(16), 2029-2074.
[http://dx.doi.org/10.1089/ars.2012.4729] [PMID: 23244576]

Garrido, N.; Griparic, L.; Jokitalo, E.; Wartiovaara, J.; van der Bliek, A.M.; Spelbrink, J.N. Composition and dynamics of human mitochondrial nucleoids. Mol. Biol. Cell, 2003, 14(4), 1583-1596.
[http://dx.doi.org/10.1091/mbc.e02-07-0399] [PMID: 12686611]

Holt, I.J.; Harding, A.E.; Morgan-Hughes, J.A. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature, 1988, 331(6158), 717-719.
[http://dx.doi.org/10.1038/331717a0] [PMID: 2830540]

Hällberg, B.M.; Larsson, N.G. Making proteins in the powerhouse. Cell Metab., 2014, 20(2), 226-240.
[http://dx.doi.org/10.1016/j.cmet.2014.07.001] [PMID: 25088301]

Alston, C.L.; Rocha, M.C.; Lax, N.Z.; Turnbull, D.M.; Taylor, R.W. The genetics and pathology of mitochondrial disease. J. Pathol., 2017, 241(2), 236-250.
[http://dx.doi.org/10.1002/path.4809] [PMID: 27659608]

Filograna, R.; Mennuni, M.; Alsina, D.; Larsson, N.G. Mitochondrial DNA copy number in human disease: The more the better? FEBS Lett., 2021, 595(8), 976-1002.
[http://dx.doi.org/10.1002/1873-3468.14021] [PMID: 33314045]

Heemels, M.T. Neurodegenerative diseases. Nature, 2016, 539(7628), 179.
[http://dx.doi.org/10.1038/539179a] [PMID: 27830810]

Klein, H.U.; Trumpff, C.; Yang, H.S.; Lee, A.J.; Picard, M.; Bennett, D.A.; De Jager, P.L. Characterization of mitochondrial DNA quantity and quality in the human aged and Alzheimer’s disease brain. Mol. Neurodegener., 2021, 16(1), 75.
[http://dx.doi.org/10.1186/s13024-021-00495-8] [PMID: 34742335]

Nissanka, N.; Moraes, C.T. Mitochondrial DNA damage and reactive oxygen species in neurodegenerative disease. FEBS Lett., 2018, 592(5), 728-742.
[http://dx.doi.org/10.1002/1873-3468.12956] [PMID: 29281123]

Buneeva, O.; Fedchenko, V.; Kopylov, A.; Medvedev, A. Mitochondrial dysfunction in Parkinson’s disease: Focus on mitochondrial DNA. Biomedicines, 2020, 8(12), 591.
[http://dx.doi.org/10.3390/biomedicines8120591] [PMID: 33321831]

De Gaetano, A.; Solodka, K.; Zanini, G.; Selleri, V.; Mattioli, A.V.; Nasi, M.; Pinti, M. Molecular mechanisms of mtDNA-mediated inflammation. Cells, 2021, 10(11), 2898.
[http://dx.doi.org/10.3390/cells10112898] [PMID: 34831121]

Mishra, P.; Chan, D.C. Mitochondrial dynamics and inheritance during cell division, development and disease. Nat. Rev. Mol. Cell Biol., 2014, 15(10), 634-646.
[http://dx.doi.org/10.1038/nrm3877] [PMID: 25237825]

Gustafsson, C.M.; Falkenberg, M.; Larsson, N.G. Maintenance and expression of mammalian mitochondrial DNA. Annu. Rev. Biochem., 2016, 85(1), 133-160.
[http://dx.doi.org/10.1146/annurev-biochem-060815-014402] [PMID: 27023847]

El-Hattab, A.W.; Craigen, W.J.; Scaglia, F. Mitochondrial DNA maintenance defects. Biochim. Biophys. Acta Mol. Basis Dis., 2017, 1863(6), 1539-1555.
[http://dx.doi.org/10.1016/j.bbadis.2017.02.017] [PMID: 28215579]

Zhao, M.; Wang, Y.; Li, L.; Liu, S.; Wang, C.; Yuan, Y.; Yang, G.; Chen, Y.; Cheng, J.; Lu, Y.; Liu, J. Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance. Theranostics, 2021, 11(4), 1845-1863.
[http://dx.doi.org/10.7150/thno.50905] [PMID: 33408785]

Zhao, M.; Liu, S.; Wang, C.; Wang, Y.; Wan, M.; Liu, F.; Gong, M.; Yuan, Y.; Chen, Y.; Cheng, J.; Lu, Y.; Liu, J. Mesenchymal stem cell-derived extracellular vesicles attenuate mitochondrial damage and inflammation by stabilizing mitochondrial DNA. ACS Nano, 2021, 15(1), 1519-1538.
[http://dx.doi.org/10.1021/acsnano.0c08947] [PMID: 33369392]

Campbell, C.T.; Kolesar, J.E.; Kaufman, B.A. Mitochondrial transcription factor A regulates mitochondrial transcription initiation, DNA packaging, and genome copy number. Biochim. Biophys. Acta. Gene Regul. Mech., 2012, 1819(9-10), 921-929.
[http://dx.doi.org/10.1016/j.bbagrm.2012.03.002] [PMID: 22465614]

Picca, A.; Lezza, A.M.S. Regulation of mitochondrial biogenesis through TFAM–mitochondrial DNA interactions. Mitochondrion, 2015, 25, 67-75.
[http://dx.doi.org/10.1016/j.mito.2015.10.001] [PMID: 26437364]

Rubio-Cosials, A.; Solà, M. U-turn DNA bending by human mitochondrial transcription factor A. Curr. Opin. Struct. Biol., 2013, 23(1), 116-124.
[http://dx.doi.org/10.1016/j.sbi.2012.12.004] [PMID: 23333034]

West, A.P.; Khoury-Hanold, W.; Staron, M.; Tal, M.C.; Pineda, C.M.; Lang, S.M.; Bestwick, M.; Duguay, B.A.; Raimundo, N.; MacDuff, D.A.; Kaech, S.M.; Smiley, J.R.; Means, R.E.; Iwasaki, A.; Shadel, G.S. Mitochondrial DNA stress primes the antiviral innate immune response. Nature, 2015, 520(7548), 553-557.
[http://dx.doi.org/10.1038/nature14156] [PMID: 25642965]

Kang, I.; Chu, C.T.; Kaufman, B.A. The mitochondrial transcription factor TFAM in neurodegeneration: Emerging evidence and mechanisms. FEBS Lett., 2018, 592(5), 793-811.
[http://dx.doi.org/10.1002/1873-3468.12989] [PMID: 29364506]

Song, L.; Shan, Y.; Lloyd, K.C.K.; Cortopassi, G.A. Mutant Twinkle increases dopaminergic neurodegeneration, mtDNA deletions and modulates Parkin expression. Hum. Mol. Genet., 2012, 21(23), 5147-5158.
[http://dx.doi.org/10.1093/hmg/dds365] [PMID: 22949510]

Hoff, K.E.; DeBalsi, K.L.; Sanchez-Quintero, M.J.; Longley, M.J.; Hirano, M.; Naini, A.B.; Copeland, W.C. Characterization of the human homozygous R182W POLG2 mutation in mitochondrial DNA depletion syndrome. PLoS One, 2018, 13(8), e0203198.
[http://dx.doi.org/10.1371/journal.pone.0203198] [PMID: 30157269]

Del Dotto, V.; Fogazza, M.; Lenaers, G.; Rugolo, M.; Carelli, V.; Zanna, C. OPA1: How much do we know to approach therapy? Pharmacol. Res., 2018, 131, 199-210.
[http://dx.doi.org/10.1016/j.phrs.2018.02.018] [PMID: 29454676]

Kukat, C.; Davies, K.M.; Wurm, C.A.; Spåhr, H.; Bonekamp, N.A.; Kühl, I.; Joos, F.; Polosa, P.L.; Park, C.B.; Posse, V.; Falkenberg, M.; Jakobs, S.; Kühlbrandt, W.; Larsson, N.G. Cross-strand binding of TFAM to a single mtDNA molecule forms the mitochondrial nucleoid. Proc. Natl. Acad. Sci. USA, 2015, 112(36), 11288-11293.
[http://dx.doi.org/10.1073/pnas.1512131112] [PMID: 26305956]

Elachouri, G.; Vidoni, S.; Zanna, C.; Pattyn, A.; Boukhaddaoui, H.; Gaget, K.; Yu-Wai-Man, P.; Gasparre, G.; Sarzi, E.; Delettre, C.; Olichon, A.; Loiseau, D.; Reynier, P.; Chinnery, P.F.; Rotig, A.; Carelli, V.; Hamel, C.P.; Rugolo, M.; Lenaers, G. OPA1 links human mitochondrial genome maintenance to mtDNA replication and distribution. Genome Res., 2011, 21(1), 12-20.
[http://dx.doi.org/10.1101/gr.108696.110] [PMID: 20974897]

Hudson, G.; Amati-Bonneau, P.; Blakely, E.L.; Stewart, J.D.; He, L.; Schaefer, A.M.; Griffiths, P.G.; Ahlqvist, K.; Suomalainen, A.; Reynier, P.; McFarland, R.; Turnbull, D.M.; Chinnery, P.F.; Taylor, R.W. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: A novel disorder of mtDNA maintenance. Brain, 2008, 131(2), 329-337.
[http://dx.doi.org/10.1093/brain/awm272] [PMID: 18065439]

Peter, B.; Falkenberg, M. TWINKLE and other human mitochondrial DNA helicases: Structure, function and disease. Genes (Basel), 2020, 11(4), 408.
[http://dx.doi.org/10.3390/genes11040408] [PMID: 32283748]

He, J.; Cooper, H.M.; Reyes, A.; Di Re, M.; Sembongi, H.; Litwin, T.R.; Gao, J.; Neuman, K.C.; Fearnley, I.M.; Spinazzola, A.; Walker, J.E.; Holt, I.J. Mitochondrial nucleoid interacting proteins support mitochondrial protein synthesis. Nucleic Acids Res., 2012, 40(13), 6109-6121.
[http://dx.doi.org/10.1093/nar/gks266] [PMID: 22453275]

Baudier, J. ATAD3 proteins: brokers of a mitochondria-endoplasmic reticulum connection in mammalian cells. Biol. Rev. Camb. Philos. Soc., 2018, 93(2), 827-844.
[http://dx.doi.org/10.1111/brv.12373] [PMID: 28941010]

Harel, T.; Yoon, W.H.; Garone, C.; Gu, S.; Coban-Akdemir, Z.; Eldomery, M.K.; Posey, J.E.; Jhangiani, S.N.; Rosenfeld, J.A.; Cho, M.T.; Fox, S.; Withers, M.; Brooks, S.M.; Chiang, T.; Duraine, L.; Erdin, S.; Yuan, B.; Shao, Y.; Moussallem, E.; Lamperti, C.; Donati, M.A.; Smith, J.D.; McLaughlin, H.M.; Eng, C.M.; Walkiewicz, M.; Xia, F.; Pippucci, T.; Magini, P.; Seri, M.; Zeviani, M.; Hirano, M.; Hunter, J.V.; Srour, M.; Zanigni, S.; Lewis, R.A.; Muzny, D.M.; Lotze, T.E.; Boerwinkle, E.; Gibbs, R.A.; Hickey, S.E.; Graham, B.H.; Yang, Y.; Buhas, D.; Martin, D.M.; Potocki, L.; Graziano, C.; Bellen, H.J.; Lupski, J.R. Recurrent de novo and biallelic variation of ATAD3A, encoding a mitochondrial membrane protein, results in distinct neurological syndromes. Am. J. Hum. Genet., 2016, 99(4), 831-845.
[http://dx.doi.org/10.1016/j.ajhg.2016.08.007] [PMID: 27640307]

Peres de Oliveira, A.; Basei, F.L.; Slepicka, P.F.; de Castro Ferezin, C.; Melo-Hanchuk, T.D.; de Souza, E.E.; Lima, T.I.; dos Santos, V.T.; Mendes, D.; Silveira, L.R.; Menck, C.F.M.; Kobarg, J. NEK10 interactome and depletion reveal new roles in mitochondria. Proteome Sci., 2020, 18(1), 4.
[http://dx.doi.org/10.1186/s12953-020-00160-w] [PMID: 32368190]

Reynolds, J.C.; Bwiza, C.P.; Lee, C. Mitonuclear genomics and aging. Hum. Genet., 2020, 139(3), 381-399.
[http://dx.doi.org/10.1007/s00439-020-02119-5] [PMID: 31997134]

DeBalsi, K.L.; Hoff, K.E.; Copeland, W.C. Role of the mitochondrial DNA replication machinery in mitochondrial DNA mutagenesis, aging and age-related diseases. Ageing Res. Rev., 2017, 33, 89-104.
[http://dx.doi.org/10.1016/j.arr.2016.04.006] [PMID: 27143693]

Zekonyte, U.; Bacman, S.R.; Moraes, C.T. DNA‐editing enzymes as potential treatments for heteroplasmic mtDNA diseases. J. Intern. Med., 2020, 287(6), 685-697.
[http://dx.doi.org/10.1111/joim.13055] [PMID: 32176378]

Thompson, L.V. Oxidative stress, mitochondria and mtDNA-mutator mice. Exp. Gerontol., 2006, 41(12), 1220-1222.
[http://dx.doi.org/10.1016/j.exger.2006.10.018] [PMID: 17126516]

Su, B.C.; Pan, C.Y.; Chen, J.Y. Antimicrobial peptide TP4 induces ROS-mediated necrosis by triggering mitochondrial dysfunction in wild-type and mutant p53 glioblastoma cells. Cancers (Basel), 2019, 11(2), 171.
[http://dx.doi.org/10.3390/cancers11020171] [PMID: 30717309]

Hu, M.; Bogoyevitch, M.A.; Jans, D.A. Subversion of host cell mitochondria by RSV to favor virus production is dependent on inhibition of mitochondrial complex I and ROS generation. Cells, 2019, 8(11), 1417.
[http://dx.doi.org/10.3390/cells8111417] [PMID: 31717900]

Guliaeva, N.A.; Kuznetsova, E.A.; Gaziev, A.I. Proteins associated with mitochondrial DNA protect it against the action of X-rays and hydrogen peroxide. Biofizika, 2006, 51(4), 692-697.
[PMID: 16909848]

Napolitano, G.; Fasciolo, G.; Venditti, P. Mitochondrial management of reactive oxygen species. Antioxidants (Basel), 2021, 10(11), 1824.
[http://dx.doi.org/10.3390/antiox10111824] [PMID: 34829696]

Yasui, M.; Kanemaru, Y.; Kamoshita, N.; Suzuki, T.; Arakawa, T.; Honma, M. Tracing the fates of site-specifically introduced DNA adducts in the human genome. DNA Repair (Amst.), 2014, 15, 11-20.
[http://dx.doi.org/10.1016/j.dnarep.2014.01.003] [PMID: 24559511]

Sanyal, T.; Bhattacharjee, P.; Bhattacharjee, S.; Bhattacharjee, P. Hypomethylation of mitochondrial D-loop and ND6 with increased mitochondrial DNA copy number in the arsenic-exposed population. Toxicology, 2018, 408, 54-61.
[http://dx.doi.org/10.1016/j.tox.2018.06.012] [PMID: 29940200]

Yu, D.; Du, Z.; Pian, L.; Li, T.; Wen, X.; Li, W.; Kim, S.J.; Xiao, J.; Cohen, P.; Cui, J.; Hoffman, A.R.; Hu, J.F. Mitochondrial DNA hypomethylation is a biomarker associated with induced senescence in human fetal heart mesenchymal stem cells. Stem Cells Int., 2017, 2017, 1-12.
[http://dx.doi.org/10.1155/2017/1764549] [PMID: 28484495]

Szczepanowska, K.; Trifunovic, A. Origins of mtDNA mutations in ageing. Essays Biochem., 2017, 61(3), 325-337.
[http://dx.doi.org/10.1042/EBC20160090] [PMID: 28698307]

Qian, Y.; Kachroo, A.H.; Yellman, C.M.; Marcotte, E.M.; Johnson, K.A. Yeast cells expressing the human mitochondrial DNA polymerase reveal correlations between polymerase fidelity and human disease progression. J. Biol. Chem., 2014, 289(9), 5970-5985.
[http://dx.doi.org/10.1074/jbc.M113.526418] [PMID: 24398692]

Kauppila, J.H.K.; Stewart, J.B. Mitochondrial DNA: Radically free of free-radical driven mutations. Biochim. Biophys. Acta Bioenerg., 2015, 1847(11), 1354-1361.
[http://dx.doi.org/10.1016/j.bbabio.2015.06.001] [PMID: 26050972]

Trifunovic, A.; Wredenberg, A.; Falkenberg, M.; Spelbrink, J.N.; Rovio, A.T.; Bruder, C.E.; Bohlooly-Y, M.; Gidlöf, S.; Oldfors, A.; Wibom, R.; Törnell, J.; Jacobs, H.T.; Larsson, N.G. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature, 2004, 429(6990), 417-423.
[http://dx.doi.org/10.1038/nature02517] [PMID: 15164064]

Anderson, A.P.; Luo, X.; Russell, W.; Yin, Y.W. Oxidative damage diminishes mitochondrial DNA polymerase replication fidelity. Nucleic Acids Res., 2020, 48(2), 817-829.
[http://dx.doi.org/10.1093/nar/gkz1018] [PMID: 31799610]

Chan, D.C. Mitochondrial Dynamics and Its Involvement in Disease. Annu. Rev. Pathol., 2020, 15(1), 235-259.
[http://dx.doi.org/10.1146/annurev-pathmechdis-012419-032711] [PMID: 31585519]

Carelli, V.; Maresca, A.; Caporali, L.; Trifunov, S.; Zanna, C.; Rugolo, M. Mitochondria: Biogenesis and mitophagy balance in segregation and clonal expansion of mitochondrial DNA mutations. Int. J. Biochem. Cell Biol., 2015, 63, 21-24.
[http://dx.doi.org/10.1016/j.biocel.2015.01.023] [PMID: 25666555]

Aryaman, J.; Bowles, C.; Jones, N.S.; Johnston, I.G. Mitochondrial network state scales mtDNA genetic dynamics. Genetics, 2019, 212(4), 1429-1443.
[http://dx.doi.org/10.1534/genetics.119.302423] [PMID: 31253641]

Lee, J.E.; Westrate, L.M.; Wu, H.; Page, C.; Voeltz, G.K. Multiple dynamin family members collaborate to drive mitochondrial division. Nature, 2016, 540(7631), 139-143.
[http://dx.doi.org/10.1038/nature20555] [PMID: 27798601]

Olichon, A.; Baricault, L.; Gas, N.; Guillou, E.; Valette, A.; Belenguer, P.; Lenaers, G. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J. Biol. Chem., 2003, 278(10), 7743-7746.
[http://dx.doi.org/10.1074/jbc.C200677200] [PMID: 12509422]

Pellino, G.; Faggioli, R.; Galuppi, A.; Leon, A.; Fusco, C.; Tugnoli, V.; Suppiej, A. Mitofusin 2: The missing link between mtDNA maintenance defects and neurotransmitter disorders. Mitochondrion, 2021, 61, 159-164.
[http://dx.doi.org/10.1016/j.mito.2021.09.011] [PMID: 34600155]

Twig, G.; Elorza, A.; Molina, A.J.A.; Mohamed, H.; Wikstrom, J.D.; Walzer, G.; Stiles, L.; Haigh, S.E.; Katz, S.; Las, G.; Alroy, J.; Wu, M.; Py, B.F.; Yuan, J.; Deeney, J.T.; Corkey, B.E.; Shirihai, O.S. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J., 2008, 27(2), 433-446.
[http://dx.doi.org/10.1038/sj.emboj.7601963] [PMID: 18200046]

Gomes, L.C.; Benedetto, G.D.; Scorrano, L. During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat. Cell Biol., 2011, 13(5), 589-598.
[http://dx.doi.org/10.1038/ncb2220] [PMID: 21478857]

Suen, D.F.; Narendra, D.P.; Tanaka, A.; Manfredi, G.; Youle, R.J. Parkin overexpression selects against a deleterious mtDNA mutation in heteroplasmic cybrid cells. Proc. Natl. Acad. Sci. USA, 2010, 107(26), 11835-11840.
[http://dx.doi.org/10.1073/pnas.0914569107] [PMID: 20547844]

Hashimoto, M.; Bacman, S.R.; Peralta, S.; Falk, M.J.; Chomyn, A.; Chan, D.C.; Williams, S.L.; Moraes, C.T. MitoTALEN: A general approach to reduce mutant mtDNA loads and restore oxidative phosphorylation function in mitochondrial diseases. Mol. Ther., 2015, 23(10), 1592-1599.
[http://dx.doi.org/10.1038/mt.2015.126] [PMID: 26159306]

Ghosh, A.; Bhattacharjee, S.; Chowdhuri, S.P.; Mallick, A.; Rehman, I.; Basu, S.; Das, B.B. SCAN1-TDP1 trapping on mitochondrial DNA promotes mitochondrial dysfunction and mitophagy. Sci. Adv., 2019, 5(11), eaax9778.
[http://dx.doi.org/10.1126/sciadv.aax9778] [PMID: 31723605]

Gao, A.; Jiang, J.; Xie, F.; Chen, L. Bnip3 in mitophagy: Novel insights and potential therapeutic target for diseases of secondary mitochondrial dysfunction. Clin. Chim. Acta, 2020, 506, 72-83.
[http://dx.doi.org/10.1016/j.cca.2020.02.024] [PMID: 32092316]

Dombi, E.; Mortiboys, H.; Poulton, J. Modulating mitophagy in mitochondrial disease. Curr. Med. Chem., 2019, 25(40), 5597-5612.
[http://dx.doi.org/10.2174/0929867324666170616101741] [PMID: 28618992]

Twig, G.; Shirihai, O.S. The interplay between mitochondrial dynamics and mitophagy. Antioxid. Redox Signal., 2011, 14(10), 1939-1951.
[http://dx.doi.org/10.1089/ars.2010.3779] [PMID: 21128700]

Herst, P.M.; Rowe, M.R.; Carson, G.M.; Berridge, M.V. Functional mitochondria in health and disease. Front. Endocrinol. (Lausanne), 2017, 8, 296.
[http://dx.doi.org/10.3389/fendo.2017.00296] [PMID: 29163365]

Corti, O.; Blomgren, K.; Poletti, A.; Beart, P.M. Autophagy in neurodegeneration: New insights underpinning therapy for neurological diseases. J. Neurochem., 2020, 154(4), 354-371.
[http://dx.doi.org/10.1111/jnc.15002] [PMID: 32149395]

Sliter, D.A.; Martinez, J.; Hao, L.; Chen, X.; Sun, N.; Fischer, T.D.; Burman, J.L.; Li, Y.; Zhang, Z.; Narendra, D.P.; Cai, H.; Borsche, M.; Klein, C.; Youle, R.J. Parkin and PINK1 mitigate STING-induced inflammation. Nature, 2018, 561(7722), 258-262.
[http://dx.doi.org/10.1038/s41586-018-0448-9] [PMID: 30135585]

Matheoud, D.; Cannon, T.; Voisin, A.; Penttinen, A.M.; Ramet, L.; Fahmy, A.M.; Ducrot, C.; Laplante, A.; Bourque, M.J.; Zhu, L.; Cayrol, R.; Le Campion, A.; McBride, H.M.; Gruenheid, S.; Trudeau, L.E.; Desjardins, M. Intestinal infection triggers Parkinson’s disease-like symptoms in Pink1 −/− mice. Nature, 2019, 571(7766), 565-569.
[http://dx.doi.org/10.1038/s41586-019-1405-y] [PMID: 31316206]

Malena, A.; Pantic, B.; Borgia, D.; Sgarbi, G.; Solaini, G.; Holt, I.J.; Spinazzola, A.; Perissinotto, E.; Sandri, M.; Baracca, A.; Vergani, L. Mitochondrial quality control: Cell-type-dependent responses to pathological mutant mitochondrial DNA. Autophagy, 2016, 12(11), 2098-2112.
[http://dx.doi.org/10.1080/15548627.2016.1226734] [PMID: 27627835]

Kandul, N.P.; Zhang, T.; Hay, B.A.; Guo, M. Selective removal of deletion-bearing mitochondrial DNA in heteroplasmic Drosophila. Nat. Commun., 2016, 7(1), 13100.
[http://dx.doi.org/10.1038/ncomms13100] [PMID: 27841259]

Ma, H.; Xu, H.; O’Farrell, P.H. Transmission of mitochondrial mutations and action of purifying selection in Drosophila melanogaster. Nat. Genet., 2014, 46(4), 393-397.
[http://dx.doi.org/10.1038/ng.2919] [PMID: 24614071]

Pickrell, A.M.; Huang, C.H.; Kennedy, S.R.; Ordureau, A.; Sideris, D.P.; Hoekstra, J.G.; Harper, J.W.; Youle, R.J. Endogenous parkin preserves dopaminergic substantia nigral neurons following mitochondrial DNA mutagenic stress. Neuron, 2015, 87(2), 371-381.
[http://dx.doi.org/10.1016/j.neuron.2015.06.034] [PMID: 26182419]

Moretton, A.; Morel, F.; Macao, B.; Lachaume, P.; Ishak, L.; Lefebvre, M.; Garreau-Balandier, I.; Vernet, P.; Falkenberg, M.; Farge, G. Selective mitochondrial DNA degradation following double-strand breaks. PLoS One, 2017, 12(4), e0176795.
[http://dx.doi.org/10.1371/journal.pone.0176795] [PMID: 28453550]

Sun, N.; Yun, J.; Liu, J.; Malide, D.; Liu, C.; Rovira, I.I.; Holmström, K.M.; Fergusson, M.M.; Yoo, Y.H.; Combs, C.A.; Finkel, T. Measuring in vivo mitophagy. Mol. Cell, 2015, 60(4), 685-696.
[http://dx.doi.org/10.1016/j.molcel.2015.10.009] [PMID: 26549682]

Marin, J.J.G.; Hernandez, A.; Revuelta, I.E.; Gonzalez-Sanchez, E.; Gonzalez-Buitrago, J.M.; Perez, M.J. Mitochondrial genome depletion in human liver cells abolishes bile acid-induced apoptosis: Role of the Akt/mTOR survival pathway and Bcl-2 family proteins. Free Radic. Biol. Med., 2013, 61, 218-228.
[http://dx.doi.org/10.1016/j.freeradbiomed.2013.04.002] [PMID: 23597504]

Yang, X.; Zhang, R.; Nakahira, K.; Gu, Z. Mitochondrial DNA mutation, diseases, and nutrient-regulated mitophagy. Annu. Rev. Nutr., 2019, 39(1), 201-226.
[http://dx.doi.org/10.1146/annurev-nutr-082018-124643] [PMID: 31433742]

Knorre, D.A. Intracellular quality control of mitochondrial DNA: evidence and limitations. Philos. Trans. R. Soc. Lond. B Biol. Sci., 2020, 375(1790), 20190176.
[http://dx.doi.org/10.1098/rstb.2019.0176] [PMID: 31787047]

Dickson-Murray, E.; Nedara, K.; Modjtahedi, N.; Tokatlidis, K. The Mia40/CHCHD4 oxidative folding system: Redox regulation and signaling in the mitochondrial intermembrane space. Antioxidants (Basel), 2021, 10(4), 592.
[http://dx.doi.org/10.3390/antiox10040592] [PMID: 33921425]

Al Amir Dache, Z.; Otandault, A.; Tanos, R.; Pastor, B.; Meddeb, R.; Sanchez, C.; Arena, G.; Lasorsa, L.; Bennett, A.; Grange, T.; El Messaoudi, S.; Mazard, T.; Prevostel, C.; Thierry, A.R. Blood contains circulating cell‐free respiratory competent mitochondria. FASEB J., 2020, 34(3), 3616-3630.
[http://dx.doi.org/10.1096/fj.201901917RR] [PMID: 31957088]

Pérez-Treviño, P.; Velásquez, M.; García, N. Mechanisms of mitochondrial DNA escape and its relationship with different metabolic diseases. Biochim. Biophys. Acta Mol. Basis Dis., 2020, 1866(6), 165761.
[http://dx.doi.org/10.1016/j.bbadis.2020.165761] [PMID: 32169503]

Picca, A.; Calvani, R.; Coelho-Junior, H.J.; Marzetti, E. Cell death and inflammation: the role of mitochondria in health and disease. Cells, 2021, 10(3), 537.
[http://dx.doi.org/10.3390/cells10030537] [PMID: 33802550]

Zhao, Y.; Liu, B.; Xu, L.; Yu, S.; Fu, J.; Wang, J.; Yan, X.; Su, J. ROS-induced mtDNA release: The emerging messenger for communication between neurons and innate immune cells during neurodegenerative disorder progression. Antioxidants, 2021, 10(12), 1917.
[http://dx.doi.org/10.3390/antiox10121917] [PMID: 34943020]

Bernardi, P. Why F-ATP Synthase remains a strong candidate as the mitochondrial permeability transition pore. Front. Physiol., 2018, 9, 1543.
[http://dx.doi.org/10.3389/fphys.2018.01543] [PMID: 30443222]

Urbani, A.; Giorgio, V.; Carrer, A.; Franchin, C.; Arrigoni, G.; Jiko, C.; Abe, K.; Maeda, S.; Shinzawa-Itoh, K.; Bogers, J.F.M.; McMillan, D.G.G.; Gerle, C.; Szabò, I.; Bernardi, P. Purified F-ATP synthase forms a Ca2+-dependent high-conductance channel matching the mitochondrial permeability transition pore. Nat. Commun., 2019, 10(1), 4341.
[http://dx.doi.org/10.1038/s41467-019-12331-1] [PMID: 31554800]

Riley, J.S.; Quarato, G.; Cloix, C.; Lopez, J.; O’Prey, J.; Pearson, M.; Chapman, J.; Sesaki, H.; Carlin, L.M.; Passos, J.F.; Wheeler, A.P.; Oberst, A.; Ryan, K.M.; Tait, S.W.G. Mitochondrial inner membrane permeabilisation enables mt DNA release during apoptosis. EMBO J., 2018, 37(17), e99238.
[http://dx.doi.org/10.15252/embj.201899238] [PMID: 30049712]

Sugiura, A.; McLelland, G.L.; Fon, E.A.; McBride, H.M. A new pathway for mitochondrial quality control: mitochondrial‐derived vesicles. EMBO J., 2014, 33(19), 2142-2156.
[http://dx.doi.org/10.15252/embj.201488104] [PMID: 25107473]

Li, W.; Li, Y.; Siraj, S.; Jin, H.; Fan, Y.; Yang, X.; Huang, X.; Wang, X.; Wang, J.; Liu, L.; Du, L.; Chen, Q. FUN14 Domain‐containing 1–mediated mitophagy suppresses hepatocarcinogenesis by inhibition of inflammasome activation in mice. Hepatology, 2019, 69(2), 604-621.
[http://dx.doi.org/10.1002/hep.30191] [PMID: 30053328]

Contis, A.; Mitrovic, S.; Lavie, J.; Douchet, I.; Lazaro, E.; Truchetet, M.E.; Goizet, C.; Contin-Bordes, C.; Schaeverbeke, T.; Blanco, P.; Rossignol, R.; Faustin, B.; Richez, C.; Duffau, P. Neutrophil-derived mitochondrial DNA promotes receptor activator of nuclear factor κB and its ligand signalling in rheumatoid arthritis. Rheumatology (Oxford), 2017, 56(7), 1200-1205.
[http://dx.doi.org/10.1093/rheumatology/kex041] [PMID: 28340056]

Yoo, S.M.; Park, J.; Kim, S.H.; Jung, Y.K. Emerging perspectives on mitochondrial dysfunction and inflammation in Alzheimer’s disease. BMB Rep., 2020, 53(1), 35-46.
[http://dx.doi.org/10.5483/BMBRep.2020.53.1.274] [PMID: 31818363]

Zhang, X.; Wang, R.; Hu, D.; Sun, X.; Fujioka, H.; Lundberg, K.; Chan, E.R.; Wang, Q.; Xu, R.; Flanagan, M.E.; Pieper, A.A.; Qi, X. Oligodendroglial glycolytic stress triggers inflammasome activation and neuropathology in Alzheimer’s disease. Sci. Adv., 2020, 6(49), eabb8680.
[http://dx.doi.org/10.1126/sciadv.abb8680] [PMID: 33277246]

Mottis, A.; Herzig, S.; Auwerx, J. Mitocellular communication: Shaping health and disease. Science, 2019, 366(6467), 827-832.
[http://dx.doi.org/10.1126/science.aax3768] [PMID: 31727828]

Zhong, Z.; Liang, S.; Sanchez-Lopez, E.; He, F.; Shalapour, S.; Lin, X.; Wong, J.; Ding, S.; Seki, E.; Schnabl, B.; Hevener, A.L.; Greenberg, H.B.; Kisseleva, T.; Karin, M. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. Nature, 2018, 560(7717), 198-203.
[http://dx.doi.org/10.1038/s41586-018-0372-z] [PMID: 30046112]

Nakahira, K.; Haspel, J.A.; Rathinam, V.A.K.; Lee, S.J.; Dolinay, T.; Lam, H.C.; Englert, J.A.; Rabinovitch, M.; Cernadas, M.; Kim, H.P.; Fitzgerald, K.A.; Ryter, S.W.; Choi, A.M.K. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat. Immunol., 2011, 12(3), 222-230.
[http://dx.doi.org/10.1038/ni.1980] [PMID: 21151103]

Vince, J.E.; De Nardo, D.; Gao, W.; Vince, A.J.; Hall, C.; McArthur, K.; Simpson, D.; Vijayaraj, S.; Lindqvist, L.M.; Bouillet, P.; Rizzacasa, M.A.; Man, S.M.; Silke, J.; Masters, S.L.; Lessene, G.; Huang, D.C.S.; Gray, D.H.D.; Kile, B.T.; Shao, F.; Lawlor, K.E. The mitochondrial apoptotic effectors BAX/BAK activate caspase-3 and -7 to trigger NLRP3 inflammasome and caspase-8 driven IL-1β activation. Cell Rep., 2018, 25(9), 2339-2353.e4.
[http://dx.doi.org/10.1016/j.celrep.2018.10.103] [PMID: 30485804]

White, M.J.; McArthur, K.; Metcalf, D.; Lane, R.M.; Cambier, J.C.; Herold, M.J.; van Delft, M.F.; Bedoui, S.; Lessene, G.; Ritchie, M.E.; Huang, D.C.S.; Kile, B.T. Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production. Cell, 2014, 159(7), 1549-1562.
[http://dx.doi.org/10.1016/j.cell.2014.11.036] [PMID: 25525874]

Sun, J.; Zhou, Y.; Xu, B.; Li, J.; Zhang, L.; Li, D.; Zhang, S.; Wu, J.; Gao, S.; Ye, D.; Mei, W. STING/NF-κB/IL-6-mediated inflammation in microglia contributes to spared nerve injury (SNI)-induced pain initiation. J. Neuroimmune Pharmacol., 2022, 3-4, 453-469.
[http://dx.doi.org/10.1007/s11481-021-10031-6] [PMID: 34727296]

Li, S.; Li, H.; Zhang, Y.L.; Xin, Q.L.; Guan, Z.Q.; Chen, X.; Zhang, X.A.; Li, X.K.; Xiao, G.F.; Lozach, P.Y.; Cui, J.; Liu, W.; Zhang, L.K.; Peng, K. SFTSV infection induces BAK/BAX-dependent mitochondrial dna release to trigger NLRP3 inflammasome activation. Cell Rep., 2020, 30(13), 4370-4385.e7.
[http://dx.doi.org/10.1016/j.celrep.2020.02.105] [PMID: 32234474]

Rodríguez-Nuevo, A.; Díaz-Ramos, A.; Noguera, E.; Díaz-Sáez, F.; Duran, X.; Muñoz, J.P.; Romero, M.; Plana, N.; Sebastián, D.; Tezze, C.; Romanello, V.; Ribas, F.; Seco, J.; Planet, E.; Doctrow, S.R.; González, J.; Borràs, M.; Liesa, M.; Palacín, M.; Vendrell, J.; Villarroya, F.; Sandri, M.; Shirihai, O.; Zorzano, A. Mitochondrial DNA and TLR9 drive muscle inflammation upon Opa1 deficiency. EMBO J., 2018, 37(10), e96553.
[http://dx.doi.org/10.15252/embj.201796553] [PMID: 29632021]

Bajwa, E.; Pointer, C.B.; Klegeris, A. The role of mitochondrial damage-associated molecular patterns in chronic neuroinflammation. Mediators Inflamm., 2019, 2019, 1-11.
[http://dx.doi.org/10.1155/2019/4050796] [PMID: 31065234]

Mangialasche, F.; Solomon, A.; Winblad, B.; Mecocci, P.; Kivipelto, M. Alzheimer’s disease: clinical trials and drug development. Lancet Neurol., 2010, 9(7), 702-716.
[http://dx.doi.org/10.1016/S1474-4422(10)70119-8] [PMID: 20610346]

Lashley, T.; Schott, J.M.; Weston, P.; Murray, C.E.; Wellington, H.; Keshavan, A.; Foti, S.C.; Foiani, M.; Toombs, J.; Rohrer, J.D.; Heslegrave, A.; Zetterberg, H. Molecular biomarkers of Alzheimer’s disease: progress and prospects. Dis. Model. Mech., 2018, 11(5), dmm031781.
[http://dx.doi.org/10.1242/dmm.031781] [PMID: 29739861]

Sheng, B.; Wang, X.; Su, B.; Lee, H.; Casadesus, G.; Perry, G.; Zhu, X. Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer’s disease. J. Neurochem., 2012, 120(3), 419-429.
[http://dx.doi.org/10.1111/j.1471-4159.2011.07581.x] [PMID: 22077634]

Wei, W.; Keogh, M.J.; Wilson, I.; Coxhead, J.; Ryan, S.; Rollinson, S.; Griffin, H.; Kurzawa-Akanbi, M.; Santibanez-Koref, M.; Talbot, K.; Turner, M.R.; McKenzie, C.A.; Troakes, C.; Attems, J.; Smith, C.; Al Sarraj, S.; Morris, C.M.; Ansorge, O.; Pickering-Brown, S.; Ironside, J.W.; Chinnery, P.F. Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains. Acta Neuropathol. Commun., 2017, 5(1), 13.
[http://dx.doi.org/10.1186/s40478-016-0404-6] [PMID: 28153046]

Chagnon, P.; Gee, M.; Filion, M.; Robitaille, Y.; Belouchi, M.; Gauvreau, D. Phylogenetic analysis of the mitochondrial genome indicates significant differences between patients with Alzheimer disease and controls in a French-Canadian founder population. Am. J. Med. Genet., 1999, 85(1), 20-30.
[http://dx.doi.org/10.1002/(SICI)1096-8628(19990702)85:1<20:AID-AJMG6>3.0.CO;2-K] [PMID: 10377009]

Corral-Debrinski, M.; Horton, T.; Lott, M.T.; Shoffner, J.M.; McKee, A.C.; Beal, M.F.; Graham, B.H.; Wallace, D.C. Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. Genomics, 1994, 23(2), 471-476.
[http://dx.doi.org/10.1006/geno.1994.1525] [PMID: 7835898]

Xu, Y.; Xu, L.; Han, M.; Liu, X.; Li, F.; Zhou, X.; Wang, Y.; Bi, J. Altered mitochondrial DNA methylation and mitochondrial DNA copy number in an APP/PS1 transgenic mouse model of Alzheimer disease. Biochem. Biophys. Res. Commun., 2019, 520(1), 41-46.
[http://dx.doi.org/10.1016/j.bbrc.2019.09.094] [PMID: 31564416]

Antonyová, V.; Kejík, Z.; Brogyányi, T.; Kaplánek, R.; Pajková, M.; Talianová, V.; Hromádka, R.; Masařík, M.; Sýkora, D.; Mikšátková, L.; Martásek, P.; Jakubek, M. Role of mtDNA disturbances in the pathogenesis of Alzheimer’s and Parkinson’s disease. DNA Repair (Amst.), 2020, 91-92, 102871.
[http://dx.doi.org/10.1016/j.dnarep.2020.102871] [PMID: 32502755]

Lezza, A.M.S.; Mecocci, P.; Cormio, A.; Real, M.F.; Cherubini, A.; Cantatore, P.; Senin, U.; Gadaleta, M.N. Mitochondrial DNA 4977 bp deletion and OH 8 dG levels correlate in the brain of aged subjects but not Alzheimer’s disease patients. FASEB J., 1999, 13(9), 1083-1088.
[http://dx.doi.org/10.1096/fasebj.13.9.1083] [PMID: 10336891]

Nunomura, A.; Perry, G.; Aliev, G.; Hirai, K.; Takeda, A.; Balraj, E.K.; Jones, P.K.; Ghanbari, H.; Wataya, T.; Shimohama, S.; Chiba, S.; Atwood, C.S.; Petersen, R.B.; Smith, M.A. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol., 2001, 60(8), 759-767.
[http://dx.doi.org/10.1093/jnen/60.8.759] [PMID: 11487050]

Devi, L.; Prabhu, B.M.; Galati, D.F.; Avadhani, N.G.; Anandatheerthavarada, H.K. Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer’s disease brain is associated with mitochondrial dysfunction. J. Neurosci., 2006, 26(35), 9057-9068.
[http://dx.doi.org/10.1523/JNEUROSCI.1469-06.2006] [PMID: 16943564]

Reddy, P.H.; Yin, X.; Manczak, M.; Kumar, S.; Pradeepkiran, J.A.; Vijayan, M.; Reddy, A.P. Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer’s disease. Hum. Mol. Genet., 2018, 27(14), 2502-2516.
[http://dx.doi.org/10.1093/hmg/ddy154] [PMID: 29701781]

Reddy, P.H.; McWeeney, S.; Park, B.S.; Manczak, M.; Gutala, R.V.; Partovi, D.; Jung, Y.; Yau, V.; Searles, R.; Mori, M.; Quinn, J. Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer’s disease. Hum. Mol. Genet., 2004, 13(12), 1225-1240.
[http://dx.doi.org/10.1093/hmg/ddh140] [PMID: 15115763]

Wang, J.; Xiong, S.; Xie, C.; Markesbery, W.R.; Lovell, M.A. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer’s disease. J. Neurochem., 2005, 93(4), 953-962.
[http://dx.doi.org/10.1111/j.1471-4159.2005.03053.x] [PMID: 15857398]

Yan, M.H.; Wang, X.; Zhu, X. Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. Free Radic. Biol. Med., 2013, 62, 90-101.
[http://dx.doi.org/10.1016/j.freeradbiomed.2012.11.014] [PMID: 23200807]

Hoekstra, J.G.; Hipp, M.J.; Montine, T.J.; Kennedy, S.R. Mitochondrial DNA mutations increase in early stage Alzheimer disease and are inconsistent with oxidative damage. Ann. Neurol., 2016, 80(2), 301-306.
[http://dx.doi.org/10.1002/ana.24709] [PMID: 27315116]

Soltys, D.T.; Pereira, C.P.M.; Rowies, F.T.; Farfel, J.M.; Grinberg, L.T.; Suemoto, C.K.; Leite, R.E.P.; Rodriguez, R.D.; Ericson, N.G.; Bielas, J.H.; Souza-Pinto, N.C. Lower mitochondrial DNA content but not increased mutagenesis associates with decreased base excision repair activity in brains of AD subjects. Neurobiol. Aging, 2019, 73, 161-170.
[http://dx.doi.org/10.1016/j.neurobiolaging.2018.09.015] [PMID: 30359878]

Wang, Z.T.; Lu, M.H.; Zhang, Y.; Ji, W.L.; Lei, L.; Wang, W.; Fang, L.P.; Wang, L.W.; Yu, F.; Wang, J.; Li, Z.Y.; Wang, J.R.; Wang, T.H.; Dou, F.; Wang, Q.W.; Wang, X.L.; Li, S.; Ma, Q.H.; Xu, R.X. Disrupted-in-schizophrenia-1 protects synaptic plasticity in a transgenic mouse model of Alzheimer’s disease as a mitophagy receptor. Aging Cell, 2019, 18(1), e12860.
[http://dx.doi.org/10.1111/acel.12860] [PMID: 30488644]

Reddy, P.H.; Oliver, D.M.A. Amyloid beta and phosphorylated tau-induced defective autophagy and mitophagy in Alzheimer’s disease. Cells, 2019, 8(5), 488.
[http://dx.doi.org/10.3390/cells8050488] [PMID: 31121890]

Morton, H.; Kshirsagar, S.; Orlov, E.; Bunquin, L.E.; Sawant, N.; Boleng, L.; George, M.; Basu, T.; Ramasubramanian, B.; Pradeepkiran, J.A.; Kumar, S.; Vijayan, M.; Reddy, A.P.; Reddy, P.H. Defective mitophagy and synaptic degeneration in Alzheimer’s disease: Focus on aging, mitochondria and synapse. Free Radic. Biol. Med., 2021, 172, 652-667.
[http://dx.doi.org/10.1016/j.freeradbiomed.2021.07.013] [PMID: 34246776]

Fang, E.F.; Hou, Y.; Palikaras, K.; Adriaanse, B.A.; Kerr, J.S.; Yang, B.; Lautrup, S.; Hasan-Olive, M.M.; Caponio, D.; Dan, X.; Rocktäschel, P.; Croteau, D.L.; Akbari, M.; Greig, N.H.; Fladby, T.; Nilsen, H.; Cader, M.Z.; Mattson, M.P.; Tavernarakis, N.; Bohr, V.A. Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease. Nat. Neurosci., 2019, 22(3), 401-412.
[http://dx.doi.org/10.1038/s41593-018-0332-9] [PMID: 30742114]

Reeve, A.K.; Ludtmann, M.H.; Angelova, P.R.; Simcox, E.M.; Horrocks, M.H.; Klenerman, D.; Gandhi, S.; Turnbull, D.M.; Abramov, A.Y. Aggregated α-synuclein and complex I deficiency: exploration of their relationship in differentiated neurons. Cell Death Dis., 2015, 6(7), e1820.
[http://dx.doi.org/10.1038/cddis.2015.166] [PMID: 26181201]

Dodson, M.W.; Guo, M. Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson’s disease. Curr. Opin. Neurobiol., 2007, 17(3), 331-337.
[http://dx.doi.org/10.1016/j.conb.2007.04.010] [PMID: 17499497]

Tzoulis, C.; Schwarzlmüller, T.; Biermann, M.; Haugarvoll, K.; Bindoff, L.A. Mitochondrial DNA homeostasis is essential for nigrostriatal integrity. Mitochondrion, 2016, 28, 33-37.
[http://dx.doi.org/10.1016/j.mito.2016.03.003] [PMID: 26979109]

Park, J.S.; Davis, R.L.; Sue, C.M. Mitochondrial dysfunction in Parkinson’s disease: new mechanistic insights and therapeutic perspectives. Curr. Neurol. Neurosci. Rep., 2018, 18(5), 21.
[http://dx.doi.org/10.1007/s11910-018-0829-3] [PMID: 29616350]

Li, N.; Ragheb, K.; Lawler, G.; Sturgis, J.; Rajwa, B.; Melendez, J.A.; Robinson, J.P. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J. Biol. Chem., 2003, 278(10), 8516-8525.
[http://dx.doi.org/10.1074/jbc.M210432200] [PMID: 12496265]

Ikebe, S.; Tanaka, M.; Ohno, K.; Sato, W.; Hattori, K.; Kondo, T.; Mizuno, Y.; Ozawa, T. Increase of deleted mitochondrial DNA in the striatum in Parkinson’s disease and senescence. Biochem. Biophys. Res. Commun., 1990, 170(3), 1044-1048.
[http://dx.doi.org/10.1016/0006-291X(90)90497-B] [PMID: 2390073]

Gezen-Ak, D.; Alaylıoğlu, M.; Genç, G.; Şengül, B.; Keskin, E.; Sordu, P.; Güleç, Z.E.K.; Apaydın, H.; Bayram-Gürel, Ç.; Ulutin, T.; Yılmazer, S.; Ertan, S.; Dursun, E. Altered transcriptional profile of mitochondrial DNA-encoded OXPHOS subunits, mitochondria quality control genes, and intracellular ATP levels in blood samples of patients with Parkinson’s disease. J. Alzheimers Dis., 2020, 74(1), 287-307.
[http://dx.doi.org/10.3233/JAD-191164] [PMID: 32007957]

Wei Soong, N.; Hinton, D.R.; Cortopassi, G.; Arnheim, N. Mosaicism for a specific somatic mitochondrial DNA mutation in adult human brain. Nat. Genet., 1992, 2(4), 318-323.
[http://dx.doi.org/10.1038/ng1292-318] [PMID: 1303287]

Kraytsberg, Y.; Kudryavtseva, E.; McKee, A.C.; Geula, C.; Kowall, N.W.; Khrapko, K. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat. Genet., 2006, 38(5), 518-520.
[http://dx.doi.org/10.1038/ng1778] [PMID: 16604072]

Basu, S.; Xie, X.; Uhler, J.P.; Hedberg-Oldfors, C.; Milenkovic, D.; Baris, O.R.; Kimoloi, S.; Matic, S.; Stewart, J.B.; Larsson, N.G.; Wiesner, R.J.; Oldfors, A.; Gustafsson, C.M.; Falkenberg, M.; Larsson, E. Accurate mapping of mitochondrial DNA deletions and duplications using deep sequencing. PLoS Genet., 2020, 16(12), e1009242.
[http://dx.doi.org/10.1371/journal.pgen.1009242] [PMID: 33315859]

Chen, S-H.; Kuo, C-W.; Lin, T-K.; Tsai, M-H.; Liou, C-W. Dopamine therapy and the regulation of oxidative stress and mitochondrial DNA copy number in patients with Parkinson’s disease. Antioxidants (Basel), 2020, 9(11), 1159.
[http://dx.doi.org/10.3390/antiox9111159] [PMID: 33233852]

Hsieh, P.C.; Wang, C.C.; Tsai, C.L.; Yeh, Y.M.; Lee, Y.S.; Wu, Y.R. POLG R964C and GBA L444P mutations in familial Parkinson’s disease: Case report and literature review. Brain Behav., 2019, 9(5), e01281.
[http://dx.doi.org/10.1002/brb3.1281] [PMID: 30941926]

Tzoulis, C.; Tran, G.T.; Schwarzlmüller, T.; Specht, K.; Haugarvoll, K.; Balafkan, N.; Lilleng, P.K.; Miletic, H.; Biermann, M.; Bindoff, L.A. Severe nigrostriatal degeneration without clinical parkinsonism in patients with polymerase gamma mutations. Brain, 2013, 136(8), 2393-2404.
[http://dx.doi.org/10.1093/brain/awt103] [PMID: 23625061]

Kiferle, L.; Orsucci, D.; Mancuso, M.; Lo Gerfo, A.; Petrozzi, L.; Siciliano, G.; Ceravolo, R.; Bonuccelli, U. Twinkle mutation in an Italian family with external progressive ophthalmoplegia and parkinsonism: A case report and an update on the state of art. Neurosci. Lett., 2013, 556, 1-4.
[http://dx.doi.org/10.1016/j.neulet.2013.09.034] [PMID: 24076137]

Garone, C.; Rubio, J.C.; Calvo, S.E.; Naini, A.; Tanji, K.; DiMauro, S.; Mootha, V.K.; Hirano, M. MPV17 Mutations causing adult-onset multisystemic disorder with multiple mitochondrial DNA deletions. Arch. Neurol., 2012, 69(12), 1648-1651.
[http://dx.doi.org/10.1001/archneurol.2012.405] [PMID: 22964873]

Fonseca Cabral, G.; Schaan, A.P.; Cavalcante, G.C.; Sena-dos-Santos, C.; de Souza, T.P. Souza Port’s, N.M.; dos Santos Pinheiro, J.A.; Ribeiro-dos-Santos, Â.; Vidal, A.F. Nuclear and mitochondrial genome, epigenome and gut microbiome: Emerging molecular biomarkers for Parkinson’s disease. Int. J. Mol. Sci., 2021, 22(18), 9839.
[http://dx.doi.org/10.3390/ijms22189839] [PMID: 34576000]

Chen, C.; Vincent, A.E.; Blain, A.P.; Smith, A.L.; Turnbull, D.M.; Reeve, A.K. Investigation of mitochondrial biogenesis defects in single substantia nigra neurons using post-mortem human tissues. Neurobiol. Dis., 2020, 134, 104631.
[http://dx.doi.org/10.1016/j.nbd.2019.104631] [PMID: 31689514]

Isobe, C.; Abe, T.; Terayama, Y. Levels of reduced and oxidized coenzymeQ-10 and 8-hydroxy-2′-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson’s disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process. Neurosci. Lett., 2010, 469(1), 159-163.
[http://dx.doi.org/10.1016/j.neulet.2009.11.065] [PMID: 19944739]

Lin, M.T.; Cantuti-Castelvetri, I.; Zheng, K.; Jackson, K.E.; Tan, Y.B.; Arzberger, T.; Lees, A.J.; Betensky, R.A.; Beal, M.F.; Simon, D.K. Somatic mitochondrial DNA mutations in early parkinson and incidental lewy body disease. Ann. Neurol., 2012, 71(6), 850-854.
[http://dx.doi.org/10.1002/ana.23568] [PMID: 22718549]

Simon, D.K.; Mayeux, R.; Marder, K.; Kowall, N.W.; Beal, M.F.; Johns, D.R. Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson’s disease. Neurology, 2000, 54(3), 703-709.
[http://dx.doi.org/10.1212/WNL.54.3.703] [PMID: 10680807]

Giannoccaro, M.P.; La Morgia, C.; Rizzo, G.; Carelli, V. M itochondrial DNA and primary mitochondrial dysfunction in P arkinson’s disease. Mov. Disord., 2017, 32(3), 346-363.
[http://dx.doi.org/10.1002/mds.26966] [PMID: 28251677]

Sanders, L.H.; Laganière, J.; Cooper, O.; Mak, S.K.; Vu, B.J.; Huang, Y.A.; Paschon, D.E.; Vangipuram, M.; Sundararajan, R.; Urnov, F.D.; Langston, J.W.; Gregory, P.D.; Zhang, H.S.; Greenamyre, J.T.; Isacson, O.; Schüle, B. LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson’s disease patients: Reversal by gene correction. Neurobiol. Dis., 2014, 62, 381-386.
[http://dx.doi.org/10.1016/j.nbd.2013.10.013] [PMID: 24148854]

Liu, Z.; Ye, Q.; Wang, F.; Guo, Y.; Cui, R.; Wang, J.; Wang, D. Overexpression of thioredoxin reductase 1 can reduce DNA damage, mitochondrial autophagy and endoplasmic reticulum stress in Parkinson’s disease. Exp. Brain Res., 2021, 239(2), 475-490.
[http://dx.doi.org/10.1007/s00221-020-05979-5] [PMID: 33230666]

Gambardella, S.; Limanaqi, F.; Ferese, R.; Biagioni, F.; Campopiano, R.; Centonze, D.; Fornai, F. ccf-mtDNA as a potential link between the brain and immune system in neuro-immunological disorders. Front. Immunol., 2019, 10, 1064.
[http://dx.doi.org/10.3389/fimmu.2019.01064] [PMID: 31143191]

Pickrell, A.M.; Pinto, M.; Hida, A.; Moraes, C.T. Striatal dysfunctions associated with mitochondrial DNA damage in dopaminergic neurons in a mouse model of Parkinson’s disease. J. Neurosci., 2011, 31(48), 17649-17658.
[http://dx.doi.org/10.1523/JNEUROSCI.4871-11.2011] [PMID: 22131425]

Cheng, A.N.; Cheng, L.C.; Kuo, C.L.; Lo, Y.K.; Chou, H.Y.; Chen, C.H.; Wang, Y.H.; Chuang, T.H.; Cheng, S.J.; Lee, A.Y.L. Mitochondrial Lon-induced mtDNA leakage contributes to PD-L1–mediated immunoescape via STING-IFN signaling and extracellular vesicles. J. Immunother. Cancer, 2020, 8(2), e001372.
[http://dx.doi.org/10.1136/jitc-2020-001372] [PMID: 33268351]

Yang, Y.; Zhou, X.; Liu, X.; Song, R.; Gao, Y.; Wang, S. Implications of FBXW7 in neurodevelopment and neurodegeneration: molecular mechanisms and therapeutic potential. Front. Cell. Neurosci., 2021, 15, 736008.
[http://dx.doi.org/10.3389/fncel.2021.736008] [PMID: 34512273]

Picca, A.; Guerra, F.; Calvani, R.; Marini, F.; Biancolillo, A.; Landi, G.; Beli, R.; Landi, F.; Bernabei, R.; Bentivoglio, A.; Lo Monaco, M.; Bucci, C.; Marzetti, E. Mitochondrial signatures in circulating extracellular vesicles of older adults with Parkinson’s disease: results from the exosomes in Parkinson’s disease (EXPAND) study. J. Clin. Med., 2020, 9(2), 504.
[http://dx.doi.org/10.3390/jcm9020504] [PMID: 32059608]

Matheoud, D.; Sugiura, A.; Bellemare-Pelletier, A.; Laplante, A.; Rondeau, C.; Chemali, M.; Fazel, A.; Bergeron, J.J.; Trudeau, L.E.; Burelle, Y.; Gagnon, E.; McBride, H.M.; Desjardins, M. Parkinson’s disease-related proteins PINK1 and parkin repress mitochondrial antigen presentation. Cell, 2016, 166(2), 314-327.
[http://dx.doi.org/10.1016/j.cell.2016.05.039] [PMID: 27345367]

Gusella, J.F.; Wexler, N.S.; Conneally, P.M.; Naylor, S.L.; Anderson, M.A.; Tanzi, R.E.; Watkins, P.C.; Ottina, K.; Wallace, M.R.; Sakaguchi, A.Y.; Young, A.B.; Shoulson, I.; Bonilla, E.; Martin, J.B. A polymorphic DNA marker genetically linked to Huntington’s disease. Nature, 1983, 306(5940), 234-238.
[http://dx.doi.org/10.1038/306234a0] [PMID: 6316146]

Askeland, G.; Dosoudilova, Z.; Rodinova, M.; Klempir, J.; Liskova, I.; Kuśnierczyk, A.; Bjørås, M.; Nesse, G.; Klungland, A.; Hansikova, H.; Eide, L. Increased nuclear DNA damage precedes mitochondrial dysfunction in peripheral blood mononuclear cells from Huntington’s disease patients. Sci. Rep., 2018, 8(1), 9817.
[http://dx.doi.org/10.1038/s41598-018-27985-y] [PMID: 29959348]

Zhao, Y.; Sun, X.; Hu, D.; Prosdocimo, D.A.; Hoppel, C.; Jain, M.K.; Ramachandran, R.; Qi, X. ATAD3A oligomerization causes neurodegeneration by coupling mitochondrial fragmentation and bioenergetics defects. Nat. Commun., 2019, 10(1), 1371.
[http://dx.doi.org/10.1038/s41467-019-09291-x] [PMID: 30914652]

Hering, T.; Kojer, K.; Birth, N.; Hallitsch, J.; Taanman, J-W.; Orth, M. Mitochondrial cristae remodelling is associated with disrupted OPA1 oligomerisation in the Huntington’s disease R6/2 fragment model. Exp. Neurol., 2017, 288, 167-175.
[http://dx.doi.org/10.1016/j.expneurol.2016.10.017] [PMID: 27889468]

Wang, Y.; Guo, X.; Ye, K.; Orth, M.; Gu, Z. Accelerated expansion of pathogenic mitochondrial DNA heteroplasmies in Huntington’s disease. Proc. Natl. Acad. Sci. USA, 2021, 118(30), e2014610118.
[http://dx.doi.org/10.1073/pnas.2014610118] [PMID: 34301881]

Williams, S.L.; Mash, D.C.; Züchner, S.; Moraes, C.T. Somatic mtDNA mutation spectra in the aging human putamen. PLoS Genet., 2013, 9(12), e1003990.
[http://dx.doi.org/10.1371/journal.pgen.1003990] [PMID: 24339796]

Disatnik, M.H.; Joshi, A.U.; Saw, N.L.; Shamloo, M.; Leavitt, B.R.; Qi, X.; Mochly-Rosen, D. Potential biomarkers to follow the progression and treatment response of Huntington’s disease. J. Exp. Med., 2016, 213(12), 2655-2669.
[http://dx.doi.org/10.1084/jem.20160776] [PMID: 27821553]

Siddiqui, A.; Rivera-Sánchez, S.; Castro, M.R.; Acevedo-Torres, K.; Rane, A.; Torres-Ramos, C.A.; Nicholls, D.G.; Andersen, J.K.; Ayala-Torres, S. Mitochondrial DNA damage Is associated with reduced mitochondrial bioenergetics in Huntington’s disease. Free Radic. Biol. Med., 2012, 53(7), 1478-1488.
[http://dx.doi.org/10.1016/j.freeradbiomed.2012.06.008] [PMID: 22709585]

Jędrak, P.; Krygier, M.; Tońska, K.; Drozd, M.; Kaliszewska, M.; Bartnik, E.; Sołtan, W.; Sitek, E.J.; Stanisławska-Sachadyn, A.; Limon, J.; Sławek, J.; Węgrzyn, G.; Barańska, S. Mitochondrial DNA levels in Huntington disease leukocytes and dermal fibroblasts. Metab. Brain Dis., 2017, 32(4), 1237-1247.
[http://dx.doi.org/10.1007/s11011-017-0026-0] [PMID: 28508341]

Petersen, M.H.; Budtz-Jørgensen, E.; Sørensen, S.A.; Nielsen, J.E.; Hjermind, L.E.; Vinther-Jensen, T.; Nielsen, S.M.B.; Nørremølle, A. Reduction in mitochondrial DNA copy number in peripheral leukocytes after onset of Huntington’s disease. Mitochondrion, 2014, 17, 14-21.
[http://dx.doi.org/10.1016/j.mito.2014.05.001] [PMID: 24836434]

Rasola, A.; Bernardi, P. Mitochondrial permeability transition in Ca2+-dependent apoptosis and necrosis. Cell Calcium, 2011, 50(3), 222-233.
[http://dx.doi.org/10.1016/j.ceca.2011.04.007] [PMID: 21601280]

Hering, T.; Birth, N.; Taanman, J.W.; Orth, M. Selective striatal mtDNA depletion in end-stage Huntington’s disease R6/2 mice. Exp. Neurol., 2015, 266, 22-29.
[http://dx.doi.org/10.1016/j.expneurol.2015.02.004] [PMID: 25682918]

Quintanilla, R.A.; Jin, Y.N.; von Bernhardi, R.; Johnson, G.V.W. Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease. Mol. Neurodegener., 2013, 8(1), 45.
[http://dx.doi.org/10.1186/1750-1326-8-45] [PMID: 24330821]

Shirendeb, U.P.; Calkins, M.J.; Manczak, M.; Anekonda, V.; Dufour, B.; McBride, J.L.; Mao, P.; Reddy, P.H. Mutant huntingtin’s interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington’s disease. Hum. Mol. Genet., 2012, 21(2), 406-420.
[http://dx.doi.org/10.1093/hmg/ddr475] [PMID: 21997870]

Crotti, A.; Glass, C.K. The choreography of neuroinflammation in Huntington’s disease. Trends Immunol., 2015, 36(6), 364-373.
[http://dx.doi.org/10.1016/j.it.2015.04.007] [PMID: 26001312]

Vicencio, E.; Beltrán, S.; Labrador, L.; Manque, P.; Nassif, M.; Woehlbier, U. Implications of selective autophagy dysfunction for ALS pathology. Cells, 2020, 9(2), 381.
[http://dx.doi.org/10.3390/cells9020381] [PMID: 32046060]

Ladd, A.C.; Brohawn, D.G.; Thomas, R.R.; Keeney, P.M.; Berr, S.S.; Khan, S.M.; Portell, F.R.; Shakenov, M.Z.; Antkowiak, P.F.; Kundu, B.; Tustison, N.; Bennett, J.P. RNA-seq analyses reveal that cervical spinal cords and anterior motor neurons from amyotrophic lateral sclerosis subjects show reduced expression of mitochondrial DNA-encoded respiratory genes, and rhTFAM may correct this respiratory deficiency. Brain Res., 2017, 1667, 74-83.
[http://dx.doi.org/10.1016/j.brainres.2017.05.010] [PMID: 28511992]

Lopez-Gonzalez, R.; Lu, Y.; Gendron, T.F.; Karydas, A.; Tran, H.; Yang, D.; Petrucelli, L.; Miller, B.L.; Almeida, S.; Gao, F.B. Poly(GR) in C9ORF72-related ALS/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons. Neuron, 2016, 92(2), 383-391.
[http://dx.doi.org/10.1016/j.neuron.2016.09.015] [PMID: 27720481]

Barber, S.C.; Shaw, P.J. Oxidative stress in ALS: Key role in motor neuron injury and therapeutic target. Free Radic. Biol. Med., 2010, 48(5), 629-641.
[http://dx.doi.org/10.1016/j.freeradbiomed.2009.11.018] [PMID: 19969067]

Kok, J.R.; Palminha, N.M.; Dos Santos Souza, C.; El-Khamisy, S.F.; Ferraiuolo, L. DNA damage as a mechanism of neurodegeneration in ALS and a contributor to astrocyte toxicity. Cell. Mol. Life Sci., 2021, 78(15), 5707-5729.
[http://dx.doi.org/10.1007/s00018-021-03872-0] [PMID: 34173837]

Stoccoro, A.; Smith, A.R.; Mosca, L.; Marocchi, A.; Gerardi, F.; Lunetta, C.; Cereda, C.; Gagliardi, S.; Lunnon, K.; Migliore, L.; Coppedè, F. Reduced mitochondrial D-loop methylation levels in sporadic amyotrophic lateral sclerosis. Clin. Epigenetics, 2020, 12(1), 137.
[http://dx.doi.org/10.1186/s13148-020-00933-2] [PMID: 32917270]

Stoccoro, A.; Mosca, L.; Carnicelli, V.; Cavallari, U.; Lunetta, C.; Marocchi, A.; Migliore, L.; Coppedè, F. Mitochondrial DNA copy number and D-loop region methylation in carriers of amyotrophic lateral sclerosis gene mutations. Epigenomics, 2018, 10(11), 1431-1443.
[http://dx.doi.org/10.2217/epi-2018-0072] [PMID: 30088417]

Walker, C.; El-Khamisy, S.F. Perturbed autophagy and DNA repair converge to promote neurodegeneration in amyotrophic lateral sclerosis and dementia. Brain, 2018, 141(5), 1247-1262.
[http://dx.doi.org/10.1093/brain/awy076] [PMID: 29584802]

Huang, C.; Yan, S.; Zhang, Z. Maintaining the balance of TDP-43, mitochondria, and autophagy: a promising therapeutic strategy for neurodegenerative diseases. Transl. Neurodegener., 2020, 9(1), 40.
[http://dx.doi.org/10.1186/s40035-020-00219-w] [PMID: 33126923]

Davis, S.A.; Itaman, S.; Khalid-Janney, C.M.; Sherard, J.A.; Dowell, J.A.; Cairns, N.J.; Gitcho, M.A. TDP-43 interacts with mitochondrial proteins critical for mitophagy and mitochondrial dynamics. Neurosci. Lett., 2018, 678, 8-15.
[http://dx.doi.org/10.1016/j.neulet.2018.04.053] [PMID: 29715546]

Ichimura, Y.; Kominami, E.; Tanaka, K.; Komatsu, M. Selective turnover of p62/A170/SQSTM1 by autophagy. Autophagy, 2008, 4(8), 1063-1066.
[http://dx.doi.org/10.4161/auto.6826] [PMID: 18776737]

Johnson, J.O.; Glynn, S.M.; Gibbs, J.R.; Nalls, M.A.; Sabatelli, M.; Restagno, G.; Drory, V.E.; Chiò, A.; Rogaeva, E.; Traynor, B.J. Mutations in the CHCHD10 gene are a common cause of familial amyotrophic lateral sclerosis. Brain, 2014, 137(12), e311.
[http://dx.doi.org/10.1093/brain/awu265] [PMID: 25261972]

Zhou, Z.D.; Saw, W.T.; Tan, E.K. Mitochondrial CHCHD-containing proteins: Physiologic functions and link with neurodegenerative diseases. Mol. Neurobiol., 2017, 54(7), 5534-5546.
[http://dx.doi.org/10.1007/s12035-016-0099-5] [PMID: 27631878]

Bannwarth, S.; Ait-El-Mkadem, S.; Chaussenot, A.; Genin, E.C.; Lacas-Gervais, S.; Fragaki, K.; Berg-Alonso, L.; Kageyama, Y.; Serre, V.; Moore, D.G.; Verschueren, A.; Rouzier, C.; Le Ber, I.; Augé, G.; Cochaud, C.; Lespinasse, F.; N’Guyen, K.; de Septenville, A.; Brice, A.; Yu-Wai-Man, P.; Sesaki, H.; Pouget, J.; Paquis-Flucklinger, V. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain, 2014, 137(8), 2329-2345.
[http://dx.doi.org/10.1093/brain/awu138] [PMID: 24934289]

Wang, P.; Deng, J.; Dong, J.; Liu, J.; Bigio, E.H.; Mesulam, M.; Wang, T.; Sun, L.; Wang, L.; Lee, A.Y.L.; McGee, W.A.; Chen, X.; Fushimi, K.; Zhu, L.; Wu, J.Y. TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response. PLoS Genet., 2019, 15(5), e1007947.
[http://dx.doi.org/10.1371/journal.pgen.1007947] [PMID: 31100073]

Yu, C.H.; Davidson, S.; Harapas, C.R.; Hilton, J.B.; Mlodzianoski, M.J.; Laohamonthonkul, P.; Louis, C.; Low, R.R.J.; Moecking, J.; De Nardo, D.; Balka, K.R.; Calleja, D.J.; Moghaddas, F.; Ni, E.; McLean, C.A.; Samson, A.L.; Tyebji, S.; Tonkin, C.J.; Bye, C.R.; Turner, B.J.; Pepin, G.; Gantier, M.P.; Rogers, K.L.; McArthur, K.; Crouch, P.J.; Masters, S.L. TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS/STING in ALS. Cell, 2020, 183(3), 636-649.e18.
[http://dx.doi.org/10.1016/j.cell.2020.09.020] [PMID: 33031745]

Yang, Y.; Wu, H.; Kang, X.; Liang, Y.; Lan, T.; Li, T.; Tan, T.; Peng, J.; Zhang, Q.; An, G.; Liu, Y.; Yu, Q.; Ma, Z.; Lian, Y.; Soh, B.S.; Chen, Q.; Liu, P.; Chen, Y.; Sun, X.; Li, R.; Zhen, X.; Liu, P.; Yu, Y.; Li, X.; Fan, Y. Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs. Protein Cell, 2018, 9(3), 283-297.
[http://dx.doi.org/10.1007/s13238-017-0499-y] [PMID: 29318513]

Bacman, S.R.; Kauppila, J.H.K.; Pereira, C.V.; Nissanka, N.; Miranda, M.; Pinto, M.; Williams, S.L.; Larsson, N.G.; Stewart, J.B.; Moraes, C.T. MitoTALEN reduces mutant mtDNA load and restores tRNAAla levels in a mouse model of heteroplasmic mtDNA mutation. Nat. Med., 2018, 24(11), 1696-1700.
[http://dx.doi.org/10.1038/s41591-018-0166-8] [PMID: 30250143]

Gammage, P.A.; Viscomi, C.; Simard, M.L.; Costa, A.S.H.; Gaude, E.; Powell, C.A.; Van Haute, L.; McCann, B.J.; Rebelo-Guiomar, P.; Cerutti, R.; Zhang, L.; Rebar, E.J.; Zeviani, M.; Frezza, C.; Stewart, J.B.; Minczuk, M. Genome editing in mitochondria corrects a pathogenic mtDNA mutation in vivo. Nat. Med., 2018, 24(11), 1691-1695.
[http://dx.doi.org/10.1038/s41591-018-0165-9] [PMID: 30250142]

Mok, B.Y.; de Moraes, M.H.; Zeng, J.; Bosch, D.E.; Kotrys, A.V.; Raguram, A.; Hsu, F.; Radey, M.C.; Peterson, S.B.; Mootha, V.K.; Mougous, J.D.; Liu, D.R. A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing. Nature, 2020, 583(7817), 631-637.
[http://dx.doi.org/10.1038/s41586-020-2477-4] [PMID: 32641830]

Pereira, C.V.; Bacman, S.R.; Arguello, T.; Zekonyte, U.; Williams, S.L.; Edgell, D.R.; Moraes, C.T. mitoTev‐TALE: a monomeric DNA editing enzyme to reduce mutant mitochondrial DNA levels. EMBO Mol. Med., 2018, 10(9), e8084.
[http://dx.doi.org/10.15252/emmm.201708084] [PMID: 30012581]

Zinovkin, R.A.; Zamyatnin, A.A. Mitochondria-targeted drugs. Curr. Mol. Pharmacol., 2019, 12(3), 202-214.
[http://dx.doi.org/10.2174/1874467212666181127151059] [PMID: 30479224]

Bharadwaj, P.R.; Bates, K.A.; Porter, T.; Teimouri, E.; Perry, G.; Steele, J.W.; Gandy, S.; Groth, D.; Martins, R.N.; Verdile, G. Latrepirdine: molecular mechanisms underlying potential therapeutic roles in Alzheimer’s and other neurodegenerative diseases. Transl. Psychiatry, 2013, 3(12), e332.
[http://dx.doi.org/10.1038/tp.2013.97] [PMID: 24301650]

Perez Ortiz, J.M.; Swerdlow, R.H. Mitochondrial dysfunction in Alzheimer’s disease: Role in pathogenesis and novel therapeutic opportunities. Br. J. Pharmacol., 2019, 176(18), 3489-3507.
[http://dx.doi.org/10.1111/bph.14585] [PMID: 30675901]

Beal, M.F.; Oakes, D.; Shoulson, I.; Henchcliffe, C.; Galpern, W.R.; Haas, R.; Juncos, J.L.; Nutt, J.G.; Voss, T.S.; Ravina, B.; Shults, C.M.; Helles, K.; Snively, V.; Lew, M.F.; Griebner, B.; Watts, A.; Gao, S.; Pourcher, E.; Bond, L.; Kompoliti, K.; Agarwal, P.; Sia, C.; Jog, M.; Cole, L.; Sultana, M.; Kurlan, R.; Richard, I.; Deeley, C.; Waters, C.H.; Figueroa, A.; Arkun, A.; Brodsky, M.; Ondo, W.G.; Hunter, C.B.; Jimenez-Shahed, J.; Palao, A.; Miyasaki, J.M.; So, J.; Tetrud, J.; Reys, L.; Smith, K.; Singer, C.; Blenke, A.; Russell, D.S.; Cotto, C.; Friedman, J.H.; Lannon, M.; Zhang, L.; Drasby, E.; Kumar, R.; Subramanian, T.; Ford, D.S.; Grimes, D.A.; Cote, D.; Conway, J.; Siderowf, A.D.; Evatt, M.L.; Sommerfeld, B.; Lieberman, A.N.; Okun, M.S.; Rodriguez, R.L.; Merritt, S.; Swartz, C.L.; Martin, W.R.W.; King, P.; Stover, N.; Guthrie, S.; Watts, R.L.; Ahmed, A.; Fernandez, H.H.; Winters, A.; Mari, Z.; Dawson, T.M.; Dunlop, B.; Feigin, A.S.; Shannon, B.; Nirenberg, M.J.; Ogg, M.; Ellias, S.A.; Thomas, C.A.; Frei, K.; Bodis-Wollner, I.; Glazman, S.; Mayer, T.; Hauser, R.A.; Pahwa, R.; Langhammer, A.; Ranawaya, R.; Derwent, L.; Sethi, K.D.; Farrow, B.; Prakash, R.; Litvan, I.; Robinson, A.; Sahay, A.; Gartner, M.; Hinson, V.K.; Markind, S.; Pelikan, M.; Perlmutter, J.S.; Hartlein, J.; Molho, E.; Evans, S.; Adler, C.H.; Duffy, A.; Lind, M.; Elmer, L.; Davis, K.; Spears, J.; Wilson, S.; Leehey, M.A.; Hermanowicz, N.; Niswonger, S.; Shill, H.A.; Obradov, S.; Rajput, A.; Cowper, M.; Lessig, S.; Song, D.; Fontaine, D.; Zadikoff, C.; Williams, K.; Blindauer, K.A.; Bergholte, J.; Propsom, C.S.; Stacy, M.A.; Field, J.; Mihaila, D.; Chilton, M.; Uc, E.Y.; Sieren, J.; Simon, D.K.; Kraics, L.; Silver, A.; Boyd, J.T.; Hamill, R.W.; Ingvoldstad, C.; Young, J.; Thomas, K.; Kostyk, S.K.; Wojcieszek, J.; Pfeiffer, R.F.; Panisset, M.; Beland, M.; Reich, S.G.; Cines, M.; Zappala, N.; Rivest, J.; Zweig, R.; Lumina, L.P.; Hilliard, C.L.; Grill, S.; Kellermann, M.; Tuite, P.; Rolandelli, S.; Kang, U.J.; Young, J.; Rao, J.; Cook, M.M.; Severt, L.; Boyar, K. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. JAMA Neurol., 2014, 71(5), 543-552.
[http://dx.doi.org/10.1001/jamaneurol.2014.131] [PMID: 24664227]

Kieburtz, K.; Tilley, B.C.; Elm, J.J.; Babcock, D.; Hauser, R.; Ross, G.W.; Augustine, A.H.; Augustine, E.U.; Aminoff, M.J.; Bodis-Wollner, I.G.; Boyd, J.; Cambi, F.; Chou, K.; Christine, C.W.; Cines, M.; Dahodwala, N.; Derwent, L.; Dewey, R.B., Jr; Hawthorne, K.; Houghton, D.J.; Kamp, C.; Leehey, M.; Lew, M.F.; Liang, G.S.L.; Luo, S.T.; Mari, Z.; Morgan, J.C.; Parashos, S.; Pérez, A.; Petrovitch, H.; Rajan, S.; Reichwein, S.; Roth, J.T.; Schneider, J.S.; Shannon, K.M.; Simon, D.K.; Simuni, T.; Singer, C.; Sudarsky, L.; Tanner, C.M.; Umeh, C.C.; Williams, K.; Wills, A.M. Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial. JAMA, 2015, 313(6), 584-593.
[http://dx.doi.org/10.1001/jama.2015.120] [PMID: 25668262]

Koentjoro, B.; Park, J.S.; Sue, C.M. Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson’s disease. Sci. Rep., 2017, 7(1), 44373.
[http://dx.doi.org/10.1038/srep44373] [PMID: 28281653]

Hayashi, G.; Jasoliya, M.; Sahdeo, S.; Saccà, F.; Pane, C.; Filla, A.; Marsili, A.; Puorro, G.; Lanzillo, R.; Brescia Morra, V.; Cortopassi, G. Dimethyl fumarate mediates Nrf2-dependent mitochondrial biogenesis in mice and humans. Hum. Mol. Genet., 2017, 26(15), 2864-2873.
[http://dx.doi.org/10.1093/hmg/ddx167] [PMID: 28460056]

Delerue, T.; Tribouillard-Tanvier, D.; Daloyau, M.; Khosrobakhsh, F.; Emorine, L.J.; Friocourt, G.; Belenguer, P.; Blondel, M.; Arnauné-Pelloquin, L. A yeast-based screening assay identifies repurposed drugs that suppress mitochondrial fusion and mtDNA maintenance defects. Dis. Model. Mech., 2019, 12(2), dmm.036558.
[http://dx.doi.org/10.1242/dmm.036558] [PMID: 30658998]

Wang, Y.; Liu, N.; Lu, B. Mechanisms and roles of mitophagy in neurodegenerative diseases. CNS Neurosci. Ther., 2019, 25(7), cns.13140.
[http://dx.doi.org/10.1111/cns.13140] [PMID: 31050206]

Gureev, A.P.; Sadovnikova, I.S.; Starkov, N.N.; Starkov, A.A.; Popov, V.N. p62-Nrf2-p62 mitophagy regulatory loop as a target for preventive therapy of neurodegenerative diseases. Brain Sci., 2020, 10(11), 847.
[http://dx.doi.org/10.3390/brainsci10110847] [PMID: 33198234]

Rahman, M.H.; Akter, R.; Bhattacharya, T.; Abdel-Daim, M.M.; Alkahtani, S.; Arafah, M.W.; Al-Johani, N.S.; Alhoshani, N.M.; Alkeraishan, N.; Alhenaky, A.; Abd-Elkader, O.H.; El-Seedi, H.R.; Kaushik, D.; Mittal, V. Resveratrol and neuroprotection: impact and its therapeutic potential in Alzheimer’s disease. Front. Pharmacol., 2020, 11, 619024.
[http://dx.doi.org/10.3389/fphar.2020.619024] [PMID: 33456444]

Coll, R.C.; Robertson, A.A.B.; Chae, J.J.; Higgins, S.C.; Muñoz-Planillo, R.; Inserra, M.C.; Vetter, I.; Dungan, L.S.; Monks, B.G.; Stutz, A.; Croker, D.E.; Butler, M.S.; Haneklaus, M.; Sutton, C.E.; Núñez, G.; Latz, E.; Kastner, D.L.; Mills, K.H.G.; Masters, S.L.; Schroder, K.; Cooper, M.A.; O’Neill, L.A.J. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat. Med., 2015, 21(3), 248-255.
[http://dx.doi.org/10.1038/nm.3806] [PMID: 25686105]

Savitt, D.; Jankovic, J. Targeting α-synuclein in Parkinson’s disease: Progress towards the development of disease-modifying therapeutics. Drugs, 2019, 79(8), 797-810.
[http://dx.doi.org/10.1007/s40265-019-01104-1] [PMID: 30982161]

Haag, S.M.; Gulen, M.F.; Reymond, L.; Gibelin, A.; Abrami, L.; Decout, A.; Heymann, M.; van der Goot, F.G.; Turcatti, G.; Behrendt, R.; Ablasser, A. Targeting STING with covalent small-molecule inhibitors. Nature, 2018, 559(7713), 269-273.
[http://dx.doi.org/10.1038/s41586-018-0287-8] [PMID: 29973723]

Vincent, J.; Adura, C.; Gao, P.; Luz, A.; Lama, L.; Asano, Y.; Okamoto, R.; Imaeda, T.; Aida, J.; Rothamel, K.; Gogakos, T.; Steinberg, J.; Reasoner, S.; Aso, K.; Tuschl, T.; Patel, D.J.; Glickman, J.F.; Ascano, M. Small molecule inhibition of cGAS reduces interferon expression in primary macrophages from autoimmune mice. Nat. Commun., 2017, 8(1), 750.
[http://dx.doi.org/10.1038/s41467-017-00833-9] [PMID: 28963528]

Russell, O.M.; Gorman, G.S.; Lightowlers, R.N.; Turnbull, D.M. Mitochondrial diseases: Hope for the future. Cell, 2020, 181(1), 168-188.
[http://dx.doi.org/10.1016/j.cell.2020.02.051] [PMID: 32220313]

Yoo, S.M.; Jung, Y.K. A Molecular approach to mitophagy and mitochondrial dynamics. Mol. Cells, 2018, 41(1), 18-26.
[PMID: 29370689]

Swerdlow, R.H. Mitochondria and mitochondrial cascades in Alzheimer’s disease. J. Alzheimers Dis., 2018, 62(3), 1403-1416.
[http://dx.doi.org/10.3233/JAD-170585] [PMID: 29036828]

Hwang, I.W.; Kwon, B.N.; Kim, H.J.; Han, S.H.; Lee, N.R.; Lim, M.H.; Kwon, H.J.; Jin, H.J. Assessment of associations between mitochondrial DNA haplogroups and attention deficit and hyperactivity disorder in Korean children. Mitochondrion, 2019, 47, 174-178.
[http://dx.doi.org/10.1016/j.mito.2018.11.003] [PMID: 30423452]

DeBrosse, S.; Parikh, S. Neurologic disorders due to mitochondrial DNA mutations. Semin. Pediatr. Neurol., 2012, 19(4), 194-202.
[http://dx.doi.org/10.1016/j.spen.2012.09.006] [PMID: 23245552]

Moya, G.E.; Rivera, P.D.; Dittenhafer-Reed, K.E. Evidence for the Role of Mitochondrial DNA Release in the Inflammatory Response in Neurological Disorders. Int. J. Mol. Sci., 2021, 22(13), 7030.
[http://dx.doi.org/10.3390/ijms22137030] [PMID: 34209978]

Stoccoro, A.; Siciliano, G.; Migliore, L.; Coppedè, F. Decreased methylation of the mitochondrial D-Loop region in late-onset Alzheimer’s disease. J. Alzheimers Dis., 2017, 59(2), 559-564.
[http://dx.doi.org/10.3233/JAD-170139] [PMID: 28655136]

Gonzalez-Hunt, C.P.; Thacker, E.A.; Toste, C.M.; Boularand, S.; Deprets, S.; Dubois, L.; Sanders, L.H. Mitochondrial DNA damage as a potential biomarker of LRRK2 kinase activity in LRRK2 Parkinson’s disease. Sci. Rep., 2020, 10(1), 17293.
[http://dx.doi.org/10.1038/s41598-020-74195-6] [PMID: 33057100]

Zambrano, K.; Barba, D.; Castillo, K.; Robayo, P.; Argueta-Zamora, D.; Sanon, S.; Arizaga, E.; Caicedo, A.; Gavilanes, A.W.D. The war against Alzheimer, the mitochondrion strikes back! Mitochondrion, 2022, 64, 125-135.
[http://dx.doi.org/10.1016/j.mito.2022.03.003] [PMID: 35337984]

Matsui, H.; Ito, J.; Matsui, N.; Uechi, T.; Onodera, O.; Kakita, A. Cytosolic dsDNA of mitochondrial origin induces cytotoxicity and neurodegeneration in cellular and zebrafish models of Parkinson’s disease. Nat. Commun., 2021, 12(1), 3101.
[http://dx.doi.org/10.1038/s41467-021-23452-x] [PMID: 34035300]

Onyango, I.; Bennett, J.; Stokin, G. Regulation of neuronal bioenergetics as a therapeutic strategy in neurodegenerative diseases. Neural Regen. Res., 2021, 16(8), 1467-1482.
[http://dx.doi.org/10.4103/1673-5374.303007] [PMID: 33433460]

Caicedo, A.; Zambrano, K.; Sanon, S.; Luis Vélez, J.; Montalvo, M.; Jara, F.; Moscoso, S.A.; Vélez, P.; Maldonado, A.; Velarde, G. The diversity and coexistence of extracellular mitochondria in circulation: A friend or foe of the immune system. Mitochondrion, 2021, 58, 270-284.
[http://dx.doi.org/10.1016/j.mito.2021.02.014] [PMID: 33662580]

Caicedo, A.; Zambrano, K.; Sanon, S.; Gavilanes, A.W.D. Extracellular mitochondria in the cerebrospinal fluid (CSF): Potential types and key roles in central nervous system (CNS) physiology and pathogenesis. Mitochondrion, 2021, 58, 255-269.
[http://dx.doi.org/10.1016/j.mito.2021.02.006] [PMID: 33662579]

Nakamura, Y.; Park, J.H.; Hayakawa, K. Therapeutic use of extracellular mitochondria in CNS injury and disease. Exp. Neurol., 2020, 324, 113114.
[http://dx.doi.org/10.1016/j.expneurol.2019.113114] [PMID: 31734316]

Zhang, X.; Hu, D.; Shang, Y.; Qi, X. Using induced pluripotent stem cell neuronal models to study neurodegenerative diseases. Biochim. Biophys. Acta Mol. Basis Dis., 2020, 1866(4), 165431.
[http://dx.doi.org/10.1016/j.bbadis.2019.03.004] [PMID: 30898538]

Zhang, W.; Gu, G.J.; Shen, X.; Zhang, Q.; Wang, G.M.; Wang, P.J. Neural stem cell transplantation enhances mitochondrial biogenesis in a transgenic mouse model of Alzheimer’s disease–like pathology. Neurobiol. Aging, 2015, 36(3), 1282-1292.
[http://dx.doi.org/10.1016/j.neurobiolaging.2014.10.040] [PMID: 25582749]

Zaia, A.; Maponi, P.; Zannotti, M.; Casoli, T. Biocomplexity and fractality in the search of biomarkers of aging and pathology: Mitochondrial DNA profiling of Parkinson’s disease. Int. J. Mol. Sci., 2020, 21(5), 1758.
[http://dx.doi.org/10.3390/ijms21051758] [PMID: 32143500]

Zaia, A.; Maponi, P.; Di Stefano, G.; Casoli, T. Biocomplexity and fractality in the search of biomarkers of aging and pathology: Focus on mitochondrial DNA and Alzheimer’s disease. Aging Dis., 2017, 8(1), 44-56.
[http://dx.doi.org/10.14336/AD.2016.0629] [PMID: 28197358]

Santibanez-Koref, M.; Griffin, H.; Turnbull, D.M.; Chinnery, P.F.; Herbert, M.; Hudson, G. Assessing mitochondrial heteroplasmy using next generation sequencing: A note of caution. Mitochondrion, 2019, 46, 302-306.
[http://dx.doi.org/10.1016/j.mito.2018.08.003] [PMID: 30098421]

Krishnan, K.J.; Ratnaike, T.E.; De Gruyter, H.L.M.; Jaros, E.; Turnbull, D.M. Mitochondrial DNA deletions cause the biochemical defect observed in Alzheimer’s disease. Neurobiol. Aging, 2012, 33(9), 2210-2214.
[http://dx.doi.org/10.1016/j.neurobiolaging.2011.08.009] [PMID: 21925769]

de la Monte, S.M.; Luong, T.; Neely, T.R.; Robinson, D.; Wands, J.R. Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer’s disease. Lab. Invest., 2000, 80(8), 1323-1335.
[http://dx.doi.org/10.1038/labinvest.3780140] [PMID: 10950123]

Liou, C.W.; Chen, S.H.; Lin, T.K.; Tsai, M.H.; Chang, C.C. Oxidative stress biomarkers and mitochondrial DNA copy number associated with APOE4 allele and cholinesterase inhibitor therapy in patients with Alzheimer’s disease. Antioxidants (Basel), 2021, 10(12), 1971.
[http://dx.doi.org/10.3390/antiox10121971] [PMID: 34943074]

Hutchin, T.P.; Heath, P.R.; Pearson, R.C.A.; Sinclair, A.J. Mitochondrial DNA mutations in Alzheimer’s disease. Biochem. Biophys. Res. Commun., 1997, 241(2), 221-225.
[http://dx.doi.org/10.1006/bbrc.1997.7793] [PMID: 9425253]

Shoffner, J.M.; Brown, M.D.; Torroni, A.; Lott, M.T.; Cabell, M.F.; Mirra, S.S.; Beal, M.F.; Yang, C.C.; Gearing, M.; Salvo, R.; Watts, R.L.; Juncos, J.L.; Hansen, L.A.; Crain, B.J.; Fayad, M.; Reckord, C.L.; Wallace, D.C. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics, 1993, 17(1), 171-184.
[http://dx.doi.org/10.1006/geno.1993.1299] [PMID: 8104867]

Blanch, M.; Mosquera, J.L.; Ansoleaga, B.; Ferrer, I.; Barrachina, M. Altered mitochondrial DNA methylation pattern in Alzheimer disease–related pathology and in Parkinson disease. Am. J. Pathol., 2016, 186(2), 385-397.
[http://dx.doi.org/10.1016/j.ajpath.2015.10.004] [PMID: 26776077]

Stoccoro, A.; Baldacci, F.; Ceravolo, R.; Giampietri, L.; Tognoni, G.; Siciliano, G.; Migliore, L.; Coppedè, F. Increase in mitochondrial D-loop region methylation levels in mild cognitive impairment individuals. Int. J. Mol. Sci., 2022, 23(10), 5393.
[http://dx.doi.org/10.3390/ijms23105393] [PMID: 35628202]

Grünewald, A.; Rygiel, K.A.; Hepplewhite, P.D.; Morris, C.M.; Picard, M.; Turnbull, D.M. Mitochondrial DNA depletion in respiratory chain–deficient p arkinson disease neurons. Ann. Neurol., 2016, 79(3), 366-378.
[http://dx.doi.org/10.1002/ana.24571] [PMID: 26605748]

Bury, A.G.; Pyle, A.; Elson, J.L.; Greaves, L.; Morris, C.M.; Hudson, G.; Pienaar, I.S. Mitochondrial DNA changes in pedunculopontine cholinergic neurons in Parkinson disease. Ann. Neurol., 2017, 82(6), 1016-1021.
[http://dx.doi.org/10.1002/ana.25099] [PMID: 29149768]

Nido, G.S.; Dölle, C.; Flønes, I.; Tuppen, H.A.; Alves, G.; Tysnes, O.B.; Haugarvoll, K.; Tzoulis, C. Ultradeep mapping of neuronal mitochondrial deletions in Parkinson’s disease. Neurobiol. Aging, 2018, 63, 120-127.
[http://dx.doi.org/10.1016/j.neurobiolaging.2017.10.024] [PMID: 29257976]

Richter, G.; Sonnenschein, A.; Grünewald, T.; Reichmann, H.; Janetzky, B. Novel mitochondrial DNA mutations in Parkinson’s disease. J. Neural Transm. (Vienna), 2002, 109(5-6), 721-729.
[http://dx.doi.org/10.1007/s007020200060] [PMID: 12111463]

Huerta, C.; Castro, M.G.; Coto, E.; Blázquez, M.; Ribacoba, R.; Guisasola, L.M.; Salvador, C.; Martínez, C.; Lahoz, C.H.; Alvarez, V. Mitochondrial DNA polymorphisms and risk of Parkinson’s disease in Spanish population. J. Neurol. Sci., 2005, 236(1-2), 49-54.
[http://dx.doi.org/10.1016/j.jns.2005.04.016] [PMID: 15975594]

Egensperger, R.; Kösel, S.; Schnopp, N.M.; Mehraein, P.; Graeber, M.B. Association of the mitochondrial tRNAA4336G mutation with Alzheimer’s and Parkinson’s diseases. Neuropathol. Appl. Neurobiol., 1997, 23(4), 315-321.
[http://dx.doi.org/10.1111/j.1365-2990.1997.tb01301.x] [PMID: 9292870]

Coxhead, J.; Kurzawa-Akanbi, M.; Hussain, R.; Pyle, A.; Chinnery, P.; Hudson, G. Somatic mtDNA variation is an important component of Parkinson’s disease. Neurobiol. Aging, 2016, 38, 217.e1-217.e6.
[http://dx.doi.org/10.1016/j.neurobiolaging.2015.10.036] [PMID: 26639157]

Stoccoro, A.; Smith, A.R.; Baldacci, F.; Del Gamba, C.; Lo Gerfo, A.; Ceravolo, R.; Lunnon, K.; Migliore, L.; Coppedè, F. Mitochondrial D-loop region methylation and copy number in peripheral blood DNA of Parkinson’s disease patients. Genes (Basel), 2021, 12(5), 720.
[http://dx.doi.org/10.3390/genes12050720] [PMID: 34065874]

Alvarez-Mora, M.I.; Podlesniy, P.; Riazuelo, T.; Molina-Porcel, L.; Gelpi, E.; Rodriguez-Revenga, L. Reduced mtDNA copy number in the prefrontal cortex of C9ORF72 patients. Mol. Neurobiol., 2022, 59(2), 1230-1237.
[http://dx.doi.org/10.1007/s12035-021-02673-7] [PMID: 34978044]